agilon health, inc.
AGL
$1.20
-$0.01-0.83%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.79% | 23.09% | 40.40% | 54.06% | 65.46% |
| Total Other Revenue | 0.37% | 14.39% | 42.18% | 75.07% | 176.95% |
| Total Revenue | 11.76% | 23.07% | 40.41% | 54.10% | 65.62% |
| Cost of Revenue | 14.81% | 25.31% | 42.60% | 63.34% | 72.90% |
| Gross Profit | -311.49% | -127.26% | -93.05% | -129.82% | -69.74% |
| SG&A Expenses | -13.00% | -11.81% | -7.44% | -5.55% | 5.74% |
| Depreciation & Amortization | 30.86% | 34.66% | 52.48% | 118.48% | 110.51% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.46% | 23.24% | 39.49% | 58.26% | 67.63% |
| Operating Income | -49.19% | -26.74% | -22.42% | -182.30% | -125.12% |
| Income Before Tax | -52.54% | -27.11% | -27.96% | -353.96% | -176.75% |
| Income Tax Expenses | -19.08% | -26.35% | 83.44% | -103.56% | 295.73% |
| Earnings from Continuing Operations | -51.95% | -26.47% | -28.18% | -346.76% | -177.42% |
| Earnings from Discontinued Operations | 116.40% | 116.24% | 85.46% | -283.24% | -716.54% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -100.00% | -117.54% | -124.15% | -99.58% | -81.75% |
| Net Income | -5.71% | 15.00% | 0.93% | -334.16% | -239.87% |
| EBIT | -49.19% | -26.74% | -22.42% | -182.30% | -125.12% |
| EBITDA | -50.82% | -25.35% | -20.19% | -188.26% | -126.52% |
| EPS Basic | -4.31% | 16.03% | 2.24% | -333.15% | -241.94% |
| Normalized Basic EPS | -50.34% | -24.04% | -22.45% | -349.86% | -178.32% |
| EPS Diluted | -4.51% | 15.75% | 2.81% | -314.71% | -235.98% |
| Normalized Diluted EPS | -50.34% | -24.04% | -22.29% | -348.13% | -177.37% |
| Average Basic Shares Outstanding | 1.10% | 1.00% | 0.50% | 0.05% | -0.62% |
| Average Diluted Shares Outstanding | 1.10% | 1.00% | -0.32% | -0.76% | -1.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |